Skip to main content
Top
Published in: Journal of Cancer Survivorship 6/2019

Open Access 01-12-2019 | Breast Cancer | Correction

Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK

Authors: Susan E. Bromley, Anthony Matthews, Liam Smeeth, Susannah Stanway, Krishnan Bhaskaran

Published in: Journal of Cancer Survivorship | Issue 6/2019

Login to get access

Excerpt

Correction to: Journal of Cancer Survivorship (2019) 13:632–640
Metadata
Title
Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
Authors
Susan E. Bromley
Anthony Matthews
Liam Smeeth
Susannah Stanway
Krishnan Bhaskaran
Publication date
01-12-2019
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 6/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00806-5

Other articles of this Issue 6/2019

Journal of Cancer Survivorship 6/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine